Follow Slashdot stories on Twitter

 


Forgot your password?
Close
typodupeerror
×

Comment Re:Umm... (Score 1) 1233

by Dins (#44653339) Attached to: Don't Fly During Ramadan
Umm, he was flying during the last week of ramadan? It's mentioned a couple times in TFA, which, contrary to the great /. tradition I did in fact read. And it was a good read, actually, but scary. This government is out of control.

Submission + - Investigational Malaria Vaccine Found Safe and Protective

Submitted by jones_supa
jones_supa writes: An investigational malaria vaccine has been found to be safe and to offer protection against infection in healthy adults, according to the results of an early-stage clinical trial published in the journal Science. The PfSPZ Vaccine is composed of live but weakened sporozoites of the species Plasmodium falciparum, the most deadly of the malaria-causing parasites. After giving the vaccine, participants were exposed to five mosquito bites carrying the same strain. Only 3 of the 15 participants who received higher dosages of the vaccine became infected, compared to 16 of 17 participants in the lower dosage group who became infected. Among the 12 participants who received no vaccine, 11 participants became infected. In this trial it was shown in principle that sporozoites can be developed into a malaria vaccine that confers high levels of protection and is made using the good manufacturing practices that are required for vaccine licensure.

Submission + - Malaria vaccine is first to provide 100% protection in early trial (nature.com)

Submitted by ananyo
ananyo writes: A malaria vaccine has become the first to provide 100% protection against the disease, confounding critics and far surpassing any other experimental malaria vaccine tested. It will now be tested further in clinical trials in Africa. No effective malaria vaccine is available at present. The World Health Organization has set a target to develop a malaria vaccine with 80% efficacy by 2025, but until now, no vaccine has come close to that level of efficacy.
In the phase I safety trial, reported in Science, the six subjects given five doses intravenously were 100% protected from later challenge by bites of infectious mosquitoes, whereas five of six unvaccinated controls developed malaria — as did three of nine people given only four doses of the vaccine.
"The trial results constitute the most important advance in malaria vaccine development since the first demonstration of protection with radiation attenuated sporozoite immunization by mosquito bite in the 70s," says Stefan Kappe, a malaria researcher at the Seattle Biomedical Research Institute in Washington.

Submission + - Ask Slashdot: Viable Alternative to Lavabit 1

Submitted by rizole
rizole writes: As we learnt earlier today, Lavabit, an encrypted email provider, was shut down by it's owner. Pointing a finger that the US Government he writes:

I would _strongly_ recommend against anyone trusting their private data to a company with physical ties to the United States.

What alternative email provider would you recommend Edward Snowden now gets an account with?

Submission + - Acer Pulls Back From Windows to Focus on Android and Chromebook 1

Submitted by SmartAboutThings
SmartAboutThings writes: More bad news for Microsoft – Acer is apparently rethinking their Windows strategy, planning to offer less Microsoft products and focus more on products delivered by Redmond’s rival Google – Chromebooks and Android devices. This comes after Acer’s second-quarter earnings call where the Taiwanese company has posted a surprise second-quarter loss, having unexpected lower sales and rising expenses. Acer's change of plans comes after not so long ago, Asus' CEO has announced that the company will no longer make Windows RT products until Microsoft proves there's real demand.

Submission + - Super-slippery SLIPS coating now transparent and more durable (gizmag.com)

Submitted by cylonlover
cylonlover writes: Joanna Aizenberg, Ph.D. and her team at the Wyss Institute for Biologically Inspired Engineering at Harvard University have improved upon the Slippery Liquid-Infused Porous Surfaces (SLIPS) technology they developed back in 2012. The ultra smooth surface, which the team claims is the slipperiest known synthetic surface, has now been made transparent and more durable, giving it the potential to make the issues glass has with sticky liquids, frost and ice formation, and bacterial biofilms a thing of the past.

Submission + - Google puts ads on Google Maps (muktworld.com)

Submitted by sfcrazy
sfcrazy writes: While the online publications are struggling to find revenue models, Google continues to expand its ad network to other service. Google is now integrating display ads with Google Maps. With this move Google is now enabling businesses to reach out to customers in a more targeted manner.

At the same time in return of telling Google where they are users continue to get top tier services for free. (before oversensitive pseudo-privacy advocates jump at Google, you should know that every GPS and mobile device tracks your location. Google or Apple, Nokia/Microsoft maps also know where you are).

Submission + - Memory Wars May Herald In Mobile Devices With Terabytes of Capacity (computerworld.com)

Submitted by Lucas123
Lucas123 writes: With 3D NAND flash going into high production and one startup demonstrating a resistive NAND (RRAM) flash array, it may not be long before mobile devices have hundreds of gigabytes of capacity, even a terabyte with performance only limited by the bus. Samsung announced it is now mass producing three-dimensional (3D) Vertical NAND (V-NAND) chips, and start-up Crossbar said it has created a prototype of its RRAM chip. Both technologies offer many times what current NAND flash chips offer today in capacity and performance. Which technology will prevail is still up in the air, but experts believe it will be years before RRAM can challenge NAND, but it's almost inevitable that it will overtake it as even 3D NAND heads for an inevitable dead end. Others believe 3D NAND, currently at 24 layers, could reach more than 100, giving it a lifespan of five or more years.

Submission + - Malaria Vaccine nearing reality (cnn.com)

Submitted by colin_faber
colin_faber writes: Right on the heals of Bill Gates business week article discussing the importance of disease prevention and cure over technological deployment is news from CNN that U.S. researchers may have a viable vaccine for Malaria. If true this could change the lives of up to 3.3 billion people living in Malaria danger zones and allow us to do away with this disease; which kills hundreds of thousands of people.

Slashdot Top Deals

"An organization dries up if you don't challenge it with growth." -- Mark Shepherd, former President and CEO of Texas Instruments

Close